Search - tctmd.com

Displaying 821 - 840 of 980

Sort: Relevancy | Date

Presentation TVT 2021

Case Introduction: Residual ASD After TEER

Presenter: Howard Herrmann

July 20, 2021

Presentation TVT 2021

Shared Decision Making for the Management of the TAVR Patient

Presenter: Megan Coylewright

July 20, 2021

Presentation TVT 2021

Case Presentation: Iliac Dissections During Transfemoral Access/Closure: The Repair Toolbox

Presenter: Curtiss Stinis

July 20, 2021

Presentation TVT 2021

Randomized Trials Are Nice to Have but Not Always Practical!

Presenter: Martin B. Leon

July 20, 2021

Presentation TVT 2021

Randomized Trials Are a Must!

Presenter: Jason H. Rogers

July 20, 2021

Presentation TVT 2021

Considerations for Index Valve Implantation

Presenter: Guilherme F. Attizzani

July 20, 2021

Presentation TVT 2021

Case Presentation: Moderate-Severe PVL After TAVR: What Now?

Presenter: Anita Asgar

July 20, 2021

Presentation TVT 2021

Not Today, and Probably Not Tomorrow!

Presenter: David H. Adams

July 20, 2021

Presentation TVT 2021

Balancing Contemporary Bicuspid Data

Presenter: John Forrest

July 20, 2021

Presentation TVT 2021

Case Resolution: The Valve Has Left the Annulus: Embolization Misadventures

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Ready for Prime Time Today!

Presenter: Saibal Kar

July 20, 2021

Presentation TVT 2021

Predictors of Hemodynamic Valve Deterioration

Presenter: Daniel O'Hair

July 20, 2021

Presentation TVT 2021

Case Presentation: The Valve Has Left the Annulus: Embolization Misadventures

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Case Resolution: Coronary Occlusion During TAVR: The Bad and the Ugly

Presenter: Azeem Latib

July 20, 2021

Presentation TVT 2021

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

Presenter: Milton Packer

July 20, 2021

Presentation TVT 2021

Complete 2-year Follow-Up from Evolut Low Risk Trial

Presenter: John Forrest

July 20, 2021

Presentation TVT 2021

Try Maximally-Tolerated GDMT First!

Presenter: JoAnn Lindenfeld

July 20, 2021

Presentation TVT 2021

Case Presentation: Coronary Occlusion During TAVR: The Bad and the Ugly

Presenter: Azeem Latib

July 20, 2021

Presentation TVT 2021

What Are We Measuring in TAVR PPM and Does It Impact Clinical Outcomes: Making Sense of the Data

Presenter: Philippe Pibarot

July 20, 2021

Presentation TVT 2021

MitraClip and Pascal in FMR: Technical Approaches and Considerations

Presenter: Neil Fam

July 20, 2021

Advertisement

Case Introduction: Residual ASD After TEER

Shared Decision Making for the Management of the TAVR Patient

Case Presentation: Iliac Dissections During Transfemoral Access/Closure: The Repair Toolbox

Randomized Trials Are Nice to Have but Not Always Practical!

Randomized Trials Are a Must!

Considerations for Index Valve Implantation

Case Presentation: Moderate-Severe PVL After TAVR: What Now?

Not Today, and Probably Not Tomorrow!

Balancing Contemporary Bicuspid Data

Case Resolution: The Valve Has Left the Annulus: Embolization Misadventures

Ready for Prime Time Today!

Predictors of Hemodynamic Valve Deterioration

Case Presentation: The Valve Has Left the Annulus: Embolization Misadventures

Case Resolution: Coronary Occlusion During TAVR: The Bad and the Ugly

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

Complete 2-year Follow-Up from Evolut Low Risk Trial

Try Maximally-Tolerated GDMT First!

Case Presentation: Coronary Occlusion During TAVR: The Bad and the Ugly

What Are We Measuring in TAVR PPM and Does It Impact Clinical Outcomes: Making Sense of the Data

MitraClip and Pascal in FMR: Technical Approaches and Considerations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content